Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie L Croucher

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Expert Opinion on Therapeutic Targets|January 7, 2014
Therapeutic targets for neuroblastomasGarrett M Brodeur, Radhika Iyer, Jamie L Croucher, et al.
Cancer Chemotherapy and Pharmacology|November 15, 2014
TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenograftsJamie L Croucher, Radhika Iyer, Nanxin Li, et al.
Cancer Letters|February 17, 2015
Nanoparticle delivery of an SN38 conjugate is more effective than irinotecan in a mouse model of neuroblastomaRadhika Iyer, Jamie L Croucher, Michael Chorny, et al.
Biomaterials|March 16, 2015
Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapyIvan S Alferiev, Radhika Iyer, Jamie L Croucher, et al.
Cancer Letters|January 23, 2016
Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse modelRadhika Iyer, Lea Wehrmann, Rebecca L Golden, et al.
Oncology Reports|April 23, 2020
RET receptor expression and interaction with TRK receptors in neuroblastomasLaura H Tetri, Venkatadri Kolla, Rebecca L Golden, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Targets|January 7, 2014
Therapeutic targets for neuroblastomasGarrett M Brodeur, Radhika Iyer, Jamie L Croucher, et al.
Cancer Chemotherapy and Pharmacology|November 15, 2014
TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenograftsJamie L Croucher, Radhika Iyer, Nanxin Li, et al.
Cancer Letters|February 17, 2015
Nanoparticle delivery of an SN38 conjugate is more effective than irinotecan in a mouse model of neuroblastomaRadhika Iyer, Jamie L Croucher, Michael Chorny, et al.
Biomaterials|March 16, 2015
Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapyIvan S Alferiev, Radhika Iyer, Jamie L Croucher, et al.
Cancer Letters|January 23, 2016
Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse modelRadhika Iyer, Lea Wehrmann, Rebecca L Golden, et al.
Oncology Reports|April 23, 2020
RET receptor expression and interaction with TRK receptors in neuroblastomasLaura H Tetri, Venkatadri Kolla, Rebecca L Golden, et al.
Pageof 1